SHEELA REDDY: Open Payments
NPI 1700045424 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$111 in 5 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $111
Food & beverage: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 2 | $46 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: ARISTADA, INVEGA SUSTENNA, CAPLYTA, INGREZZA.
Industry payments across CA — which companies pay providers there.
